Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients.
about
Potential Utility of FDG PET-CT as a Non-invasive Tool for Monitoring Local Immune Responses.Prospective evaluation of plasma Epstein-Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma.Cancer-associated fibroblasts enhance tumor 18F-FDG uptake and contribute to the intratumor heterogeneity of PET-CT.
P2860
Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients.
@en
type
label
Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients.
@en
prefLabel
Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients.
@en
P2093
P2860
P921
P1433
P1476
Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients
@en
P2093
P2860
P356
10.1097/MD.0000000000006721
P407
P50
P5008
P577
2017-04-01T00:00:00Z